{"as_of":"2026-10-20","cancer":"女性侵襲性乳癌，不含原位癌","unit":"每十萬相應女性人口／年","rows":[{"country":"台灣","year":2013,"cases":11445,"population":null,"crude_rate":97.91,"original_asr":70.09,"original_standard":"WHO 2000","common_segi_lower":null,"common_segi_upper":null,"source":"TW","scope":"全國女性","note":"同一份回溯修訂 CSV；2023 Segi 率另核對年報第72頁。"},{"country":"台灣","year":2021,"cases":15656,"population":null,"crude_rate":132.72,"original_asr":83.61,"original_standard":"WHO 2000","common_segi_lower":null,"common_segi_upper":null,"source":"TW","scope":"全國女性","note":"同一份回溯修訂 CSV；2023 Segi 率另核對年報第72頁。"},{"country":"台灣","year":2022,"cases":17539,"population":null,"crude_rate":149.07,"original_asr":92.86,"original_standard":"WHO 2000","common_segi_lower":null,"common_segi_upper":null,"source":"TW","scope":"全國女性","note":"同一份回溯修訂 CSV；2023 Segi 率另核對年報第72頁。"},{"country":"台灣","year":2023,"cases":17779,"population":null,"crude_rate":149.82,"original_asr":91.2,"original_standard":"WHO 2000","common_segi_lower":84.28,"common_segi_upper":84.28,"source":"TW","scope":"全國女性","note":"同一份回溯修訂 CSV；2023 Segi 率另核對年報第72頁。"},{"country":"日本","year":2013,"cases":76839,"population":null,"crude_rate":117.51238759405396,"original_asr":66.22880216681061,"original_standard":"Segi 1960","common_segi_lower":66.22880216681062,"common_segi_upper":66.22880216681062,"calculated_who2000":71.40937790836716,"source":"JP13","scope":"全國女性","note":"2013為區域登記推估全國值；2016起為全國癌症登記。"},{"country":"日本","year":2021,"cases":98782,"population":null,"crude_rate":153.190763457035,"original_asr":78.4989174185132,"original_standard":"Segi 1960","common_segi_lower":78.49891741851317,"common_segi_upper":78.49891741851317,"calculated_who2000":85.08141483718408,"source":"JP23","scope":"全國女性","note":"2013為區域登記推估全國值；2016起為全國癌症登記。"},{"country":"日本","year":2022,"cases":99770,"population":null,"crude_rate":155.431616008973,"original_asr":79.316722792408,"original_standard":"Segi 1960","common_segi_lower":79.31672279240807,"common_segi_upper":79.31672279240807,"calculated_who2000":85.91746850134228,"source":"JP23","scope":"全國女性","note":"2013為區域登記推估全國值；2016起為全國癌症登記。"},{"country":"日本","year":2023,"cases":102592,"population":null,"crude_rate":160.653940713134,"original_asr":80.920318824011,"original_standard":"Segi 1960","common_segi_lower":80.92031882401105,"common_segi_upper":80.92031882401105,"calculated_who2000":87.7417355543378,"source":"JP23","scope":"全國女性","note":"2013為區域登記推估全國值；2016起為全國癌症登記。"},{"country":"韓國","year":2013,"cases":17231,"population":null,"crude_rate":68.2,"original_asr":45.7,"original_standard":"Segi 1960","common_segi_lower":45.7,"common_segi_upper":45.7,"source":"KR13","scope":"全國女性","note":"各診斷年度研究報告，發布版本不同；不是同一發布版本的回溯序列。"},{"country":"韓國","year":2021,"cases":28720,"population":null,"crude_rate":111.6,"original_asr":68.6,"original_standard":"Segi 1960","common_segi_lower":68.6,"common_segi_upper":68.6,"source":"KR21","scope":"全國女性","note":"各診斷年度研究報告，發布版本不同；不是同一發布版本的回溯序列。"},{"country":"韓國","year":2022,"cases":29391,"population":null,"crude_rate":114.3,"original_asr":69.2,"original_standard":"Segi 1960","common_segi_lower":69.2,"common_segi_upper":69.2,"source":"KR22","scope":"全國女性","note":"各診斷年度研究報告，發布版本不同；不是同一發布版本的回溯序列。"},{"country":"韓國","year":2023,"cases":29715,"population":null,"crude_rate":115.7,"original_asr":69.7,"original_standard":"Segi 1960","common_segi_lower":69.7,"common_segi_upper":69.7,"source":"KR23","scope":"全國女性","note":"各診斷年度研究報告，發布版本不同；不是同一發布版本的回溯序列。"},{"country":"美國","year":2013,"cases":238127,"population":160601985,"crude_rate":148.2715173165512,"original_asr":127.2,"original_standard":"US 2000（不是 WHO 2000）","common_segi_lower":null,"common_segi_upper":null,"source":"US","scope":"USCS全國女性，所有族群","note":"CDC現行查詢系統同一版本；粗率由公開病例與相應人口重算。"},{"country":"美國","year":2021,"cases":284431,"population":167656063,"crude_rate":169.65148465880412,"original_asr":136.7,"original_standard":"US 2000（不是 WHO 2000）","common_segi_lower":null,"common_segi_upper":null,"source":"US","scope":"USCS全國女性，所有族群","note":"CDC現行查詢系統同一版本；粗率由公開病例與相應人口重算。"},{"country":"美國","year":2022,"cases":284897,"population":168681389,"crude_rate":168.8965224254823,"original_asr":135.2,"original_standard":"US 2000（不是 WHO 2000）","common_segi_lower":null,"common_segi_upper":null,"source":"US","scope":"USCS全國女性，所有族群","note":"CDC現行查詢系統同一版本；粗率由公開病例與相應人口重算。"},{"country":"美國","year":2023,"cases":288494,"population":170100136,"crude_rate":169.60245111150294,"original_asr":135.2,"original_standard":"US 2000（不是 WHO 2000）","common_segi_lower":97.39123742417429,"common_segi_upper":97.45907903397601,"source":"US","scope":"USCS全國女性，所有族群","note":"CDC現行查詢系統同一版本；粗率由公開病例與相應人口重算。 Segi重算採抑制格0至15例的保守範圍，並非信賴區間。"},{"country":"新加坡","year":2013,"cases":null,"population":null,"crude_rate":null,"original_asr":null,"original_standard":"Segi-Doll","common_segi_lower":null,"common_segi_upper":null,"source":"SG23","scope":"女性公民及永久居民","note":"2023為單年度。已讀舊年報以多年區間呈現乳癌資料；其他指定單年未核得，不以五年值代填。"},{"country":"新加坡","year":2021,"cases":null,"population":null,"crude_rate":null,"original_asr":null,"original_standard":"Segi-Doll","common_segi_lower":null,"common_segi_upper":null,"source":"SG23","scope":"女性公民及永久居民","note":"2023為單年度。已讀舊年報以多年區間呈現乳癌資料；其他指定單年未核得，不以五年值代填。"},{"country":"新加坡","year":2022,"cases":null,"population":null,"crude_rate":null,"original_asr":null,"original_standard":"Segi-Doll","common_segi_lower":null,"common_segi_upper":null,"source":"SG23","scope":"女性公民及永久居民","note":"2023為單年度。已讀舊年報以多年區間呈現乳癌資料；其他指定單年未核得，不以五年值代填。"},{"country":"新加坡","year":2023,"cases":3104,"population":null,"crude_rate":145.9,"original_asr":83.3,"original_standard":"Segi-Doll","common_segi_lower":83.3,"common_segi_upper":83.3,"source":"SG23","scope":"女性公民及永久居民","note":"2023為單年度。已讀舊年報以多年區間呈現乳癌資料；其他指定單年未核得，不以五年值代填。"}],"growth":[{"country":"台灣","crude_growth_2013_2023":0.5301807782657542},{"country":"日本","crude_growth_2013_2023":0.36712344972610333},{"country":"韓國","crude_growth_2013_2023":0.6964809384164223},{"country":"美國","crude_growth_2013_2023":0.1438640015358541},{"country":"新加坡","crude_growth_2013_2023":null}],"sources":{"TW":{"url":"https://www.hpa.gov.tw/Pages/ashx/GetFile.ashx?lang=c&type=1&sid=9e08758933474930a69e2946e17d63ea","detail":"國健署歷年癌症CSV；2023年報第72、503頁核對Segi及WHO標準。"},"JP13":{"url":"https://ganjoho.jp/reg_stat/statistics/data/dl/excel/cancer_incidence%281975-2015%29.xls","detail":"MCIJ全國推估；number/rate/asr工作表。"},"JP23":{"url":"https://ganjoho.jp/reg_stat/statistics/data/dl/excel/cancer_incidenceNCR%282016-2023%29.xls","detail":"日本全國癌症登記；number/rate/asr工作表。"},"KR13":{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4843732/","detail":"2013年登記統計研究，Table 1、2；女性乳癌。"},"KR21":{"url":"https://www.e-crt.org/upload/pdf/crt-2024-253.pdf","detail":"2021年登記統計研究，Table 1、2。"},"KR22":{"url":"https://www.e-crt.org/upload/pdf/crt-2025-264.pdf","detail":"2022年登記統計研究，Table 1、2。"},"KR23":{"url":"https://www.e-crt.org/upload/pdf/crt-2026-298.pdf","detail":"2023年登記統計研究，Table 1、2。"},"US":{"url":"https://gis.cdc.gov/cancerapi/DataVizApi/GetJSON/TrendsMapData_Inci_byCancerSiteID_5","detail":"由CDC公開網站程式確認接口；YearID、SexID、RaceID均核對公開selectors；2023年齡別資料另重算Segi範圍。"},"SG23":{"url":"https://isomer-user-content.by.gov.sg/737/a9695c77-40d5-4bbd-a4b9-347a0942b191/singapore-cancer-registry-annual-report-2023.pdf","detail":"Table 3.1.2，實體PDF第51頁；方法第7頁。"}},"common_2023_standard":"Segi 1960 / Doll世界標準；台灣年報稱1976世界標準，同一組年齡權重。","us_age_inputs":[{"age_ids":[1,2],"population":9113709,"count_lower":0,"count_upper":30,"segi_weight":12000},{"age_ids":[11],"population":9912913,"count_lower":0,"count_upper":15,"segi_weight":10000},{"age_ids":[3],"population":10220382,"count_lower":0,"count_upper":15,"segi_weight":9000},{"age_ids":[4],"population":10848970,"count_lower":22,"count_upper":22,"segi_weight":9000},{"age_ids":[5],"population":10793698,"count_lower":194,"count_upper":194,"segi_weight":8000},{"age_ids":[6],"population":10974079,"count_lower":1227,"count_upper":1227,"segi_weight":8000},{"age_ids":[7],"population":11761144,"count_lower":3794,"count_upper":3794,"segi_weight":6000},{"age_ids":[8],"population":11232482,"count_lower":7702,"count_upper":7702,"segi_weight":6000},{"age_ids":[9],"population":10948511,"count_lower":15684,"count_upper":15684,"segi_weight":6000},{"age_ids":[10],"population":9974556,"count_lower":21388,"count_upper":21388,"segi_weight":6000},{"age_ids":[12],"population":10407373,"count_lower":25980,"count_upper":25980,"segi_weight":5000},{"age_ids":[13],"population":10466862,"count_lower":29123,"count_upper":29123,"segi_weight":4000},{"age_ids":[14],"population":10932221,"count_lower":38044,"count_upper":38044,"segi_weight":4000},{"age_ids":[15],"population":10042785,"count_lower":42974,"count_upper":42974,"segi_weight":3000},{"age_ids":[16],"population":8331148,"count_lower":39441,"count_upper":39441,"segi_weight":2000},{"age_ids":[17],"population":6221182,"count_lower":30323,"count_upper":30323,"segi_weight":1000},{"age_ids":[18],"population":3983828,"count_lower":18436,"count_upper":18436,"segi_weight":500},{"age_ids":[19],"population":3934293,"count_lower":14161,"count_upper":14161,"segi_weight":500}],"singapore_periods":[{"period":"2013–2017","cases":10936,"crude_rate":110.1,"segi_asr":70.5},{"period":"2019–2023","cases":13935,"crude_rate":134.4,"segi_asr":78.7}],"limitations":["年齡校正不等於校正篩檢、診斷、申報或其他風險因素。","不同國家的資料修訂、居民定義與2016日本制度變化均保留註記。","新加坡未核得的單年數值保持缺值，五年病例數與年化率不得當成單一年數字。","美國Segi區間是公開抑制格造成的可計算範圍，不是統計信賴區間。","描述性比較不能確定BaP油品造成癌症增加。"]}